Abstract

Summary

Excessive artificial light at night—especially blue-wavelength light from LEDs and electronic devices—disrupts melatonin rhythms and the circadian system, increasing risks of metabolic, cardiovascular, cognitive, and oncological disorders. Lighting systems should be designed to minimize blue-light exposure at night while maximizing daytime light intensity to properly entrain the biological clock and protect health.
Abstract

Key Findings

  • Blue light produces the strongest melatonin suppression compared to other wavelengths and is therefore the most chronodisrupting at night.
  • Chronodisruption (CD) is epidemiologically associated with increased incidence of diabetes, obesity, heart disease, cognitive and affective impairment, premature aging, and some cancers.
  • Modern populations are exposed to light intensity much lower than natural daylight during the day (indoors) and much higher than natural levels at night, creating a flattened light-dark contrast that impairs circadian entrainment.
  • Melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) are identified as the key photoreceptors for non-visual, circadian light responses, meaning light intensity, timing, and spectrum must all be considered in lighting design.
Categories

Categories

Sleep & Circadian Health: Reviews how light timing, intensity, and spectrum affect melatonin rhythm and circadian entrainment, with direct implications for healthy lighting design.
The Science of Light: Covers melanopsin, ipRGCs, spectral sensitivity (blue light), and photoreceptor biology as they relate to chronodisruption and melatonin suppression.
Mood & Mental Wellness: Links chronodisruption to cognitive and affective impairment, obesity, diabetes, heart disease, and cancer risk via epidemiological evidence.
Authors

Author(s)

MA Bonmati-Carrion, R Arguelles-Prieto
Publication Date

Publication Year

2014
Citations

Number of Citations

299
View more publications